Sutro Biopharma Inc buy Truist Financial Co.
Start price
03.04.24
/
50%
€4.78
Target price
03.04.25
€16.65
Performance (%)
-22.18%
Price
05.09.24
€3.78
Summary
This prediction is currently active. The prediction for Sutro Biopharma Inc disappoints with a performance of -22.18%. This prediction currently runs until 03.04.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | -6.897% | -6.897% |
iShares Core DAX® | -3.429% | 5.085% |
iShares Nasdaq 100 | -6.121% | 0.593% |
iShares Nikkei 225® | -7.364% | 5.479% |
iShares S&P 500 | -4.366% | 2.019% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its price target lowered by analysts at Truist Financial Co. from $25.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.88
16.08.24
16.08.24
€13.63
16.08.25
16.08.25
-4.12%
05.09.24
05.09.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.14
06.09.23
06.09.23
€23.30
06.09.24
06.09.24
-8.21%
07.09.24
07.09.24